XML 44 R35.htm IDEA: XBRL DOCUMENT v3.22.2.2
Stock Compensation (Tables)
9 Months Ended
Sep. 30, 2022
Stock Compensation  
Schedule of Share Based Compensation Stock Options Activities

The following table summarizes stock option activity during the nine months ended September 30, 2022 (under both the 2012 Plan and the 2022 Plan):

Weighted

Average

Number

Weighted

Remaining

Aggregate

of Options

Average

Contractual

Intrinsic Value

    

(in thousands)

    

Exercise Price

    

Term (years)

    

(in thousands)

Outstanding at December 31, 2021

 

2,252

$

50.28

 

7.2

$

408

Granted

 

493

$

15.04

 

$

Exercised

 

(29)

$

15.01

 

$

93

Cancelled/forfeited

 

(164)

$

27.60

 

$

Expired

 

(105)

$

99.54

 

$

Outstanding at September 30, 2022

 

2,447

$

43.00

 

7.0

$

45

Expected to vest

 

954

$

21.97

 

8.7

$

45

Exercisable

 

1,493

$

56.45

 

5.9

$

Schedule of Share Based Compensation Arrangement By Share Based Payment Award Grants in Period Fair Value Assumptions

The Company estimated the fair value of stock options granted in the periods presented utilizing a Black-Scholes option-pricing model utilizing the following assumptions:

Nine Months Ended September 30, 

    

2022

    

2021

Volatility

 

66.4 - 67.7

%

65.2 - 69.3

%

Expected term (in years)

 

5.5 - 6.0

 

3.75 - 6.0

 

Risk-free rate

 

1.3 - 2.8

%  

0.4 - 0.9

%

Expected dividend yield

 

%  

%

Schedule of Share-based Compensation, Restricted Stock Units Award Activity

The following table summarizes the aggregate RSU, RSA and PRSU activity during the nine months ended September 30, 2022 (under both the 2012 Plan and the 2022 Plan):

Weighted

Number of

Average Grant Date

    

Awards

    

Fair Value

(in thousands)

Non-vested awards at December 31, 2021

 

968

$

39.58

Granted

 

819

$

15.69

Vested

(411)

$

30.74

Forfeited

 

(193)

$

38.72

Non-vested awards at September 30, 2022

 

1,183

$

26.23

Schedule of Stock Based Compensation Expense

Stock-based compensation expense has been reported in the Company’s condensed consolidated statements of operations as follows:

Three Months Ended September 30, 

Nine Months Ended September 30, 

    

2022

    

2021

    

2022

    

2021

(in thousands)

Selling, general and administrative

$

4,411

$

5,737

$

12,485

$

16,255

Research and development

 

1,377

 

1,451

 

4,173

 

4,626

Restructuring

Total stock-based compensation

$

5,788

$

7,188

$

16,658

$

20,881